1,3-beta-Glucan synthase: a useful target for antifungal drugs
- PMID: 12455412
- DOI: 10.2174/1568005014606107
1,3-beta-Glucan synthase: a useful target for antifungal drugs
Abstract
1,3-beta-glucan synthase, a multisubunit enzyme, is responsible for fungal cell wall construction, division septum deposition, and ascospore wall assembly. The catalytic subunit of this enzyme complex, an integral membrane protein, has been identified both in model yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe, and in pathogenic fungi such as Candida, Aspergillus, Cryptococcus and Pneumocystis species. The catalytic activity of the 1,3-beta-glucan synthase is regulated by a small GTPase of the Ras superfamily, the Rho-GTPase, and protein kinase C (Pkc)-like signaling molecules. It has been shown that the plasma membrane localization of this enzyme is essential for its activity. Interestingly, inhibition of 1,3-beta-glucan synthase activity by anti-fungal drugs of the lipopeptide type triggers a cell cycle feedback mechanism leading to cell cycle arrest. Recent progress in studies of molecular mechanisms of the temporal and spatial regulation of 1,3-beta-glucan synthase is presented. The implication of the cell cycle checkpoint that is activated by the anti-fungal drugs is also discussed.
Similar articles
-
Lipopeptide inhibitors of fungal glucan synthase.J Med Vet Mycol. 1997 Mar-Apr;35(2):79-86. doi: 10.1080/02681219780000961. J Med Vet Mycol. 1997. PMID: 9147267 Review.
-
Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors.Antimicrob Agents Chemother. 2000 Feb;44(2):368-77. doi: 10.1128/AAC.44.2.368-377.2000. Antimicrob Agents Chemother. 2000. PMID: 10639364 Free PMC article.
-
Papulacandin B resistance in budding and fission yeasts: isolation and characterization of a gene involved in (1,3)beta-D-glucan synthesis in Saccharomyces cerevisiae.J Bacteriol. 1995 Oct;177(20):5732-9. doi: 10.1128/jb.177.20.5732-5739.1995. J Bacteriol. 1995. PMID: 7592316 Free PMC article.
-
Piperazine propanol derivative as a novel antifungal targeting 1,3-beta-D-glucan synthase.Biol Pharm Bull. 2005 Nov;28(11):2138-41. doi: 10.1248/bpb.28.2138. Biol Pharm Bull. 2005. PMID: 16272705
-
[The mechanisms of resistance to echinocandin class of antifungal drugs].Nihon Ishinkin Gakkai Zasshi. 2009;50(2):57-66. doi: 10.3314/jjmm.50.057. Nihon Ishinkin Gakkai Zasshi. 2009. PMID: 19430179 Review. Japanese.
Cited by
-
Green Chemistry and In silico Techniques for Synthesis of Novel Pyranopyrazole and Pyrazolo-pyrano-pyrimidine Derivatives as Promising Antifungal Agents.Recent Adv Antiinfect Drug Discov. 2024;19(3):216-231. doi: 10.2174/0127724344269458231124123935. Recent Adv Antiinfect Drug Discov. 2024. PMID: 38317465
-
Antifungal Drugs.Metabolites. 2020 Mar 12;10(3):106. doi: 10.3390/metabo10030106. Metabolites. 2020. PMID: 32178468 Free PMC article. Review.
-
Endosidin 7 Specifically Arrests Late Cytokinesis and Inhibits Callose Biosynthesis, Revealing Distinct Trafficking Events during Cell Plate Maturation.Plant Physiol. 2014 Jul;165(3):1019-1034. doi: 10.1104/pp.114.241497. Epub 2014 May 23. Plant Physiol. 2014. PMID: 24858949 Free PMC article.
-
A fission yeast strain expressing human CDC25A phosphatase: a tool for selectivity studies of pharmacological inhibitors of CDC25.Curr Genet. 2004 May;45(5):283-8. doi: 10.1007/s00294-003-0483-3. Epub 2004 Jan 15. Curr Genet. 2004. PMID: 14727060
-
Echinocandin Drugs Induce Differential Effects in Cytokinesis Progression and Cell Integrity.Pharmaceuticals (Basel). 2021 Dec 20;14(12):1332. doi: 10.3390/ph14121332. Pharmaceuticals (Basel). 2021. PMID: 34959732 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases